Subscribe

  • How Can We Help You?

    Global Problem Solving from Covington: Deal with Complex Problems Anywhere in the World

Covington Represents Ceptur Therapeutics in $75M Series A Financing

Press Release January 19, 2022

  • News and Insights
  • Covington Represents Ceptur Therapeutics in $75M Series A Financing

Covington Represents Ceptur Therapeutics in $75M Series A Financing

January 19, 2022

NEW YORK—Covington advised Ceptur Therapeutics, Inc., a biotechnology company focused on developing targeted oligonucleotide therapeutics based on U1 Adaptor technology, in the completion of its $75 million Series A financing.

The Covington team included Brian K. Rosenzweig, Joe Gangitano, Max Sternberg, and Mark Edlund.

Related Professionals

Share links:

Share links:

Related Practices

Related Industries

Related Offices

Related Regions

Related News & Insights